Volume 11, Number 8—August 2005
Dispatch
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
Table A4
Preexposure (seasonal) prophylaxis trials included in the analysis
Trial | Age group, y | Intervention (no. participants) | Treatment duration |
---|---|---|---|
Hayden et al., 1999 (11) | 18–65 | Oseltamivir 75 mg 1×/d (520) | 6 weeks |
Oseltamivir 75 mg 2×/d (520) | |||
Placebo (519) | |||
Monto et al., 1999 (15) | 18–69 | Zanamivir 10 mg 1×/d (553) | 4 weeks |
Placebo (554) |